Skip to main content

Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".

Publication ,  Journal Article
James, SK; Storey, RF; Pieper, KS; Cannon, CP; Becker, RC; Steg, PG; Wallentin, L; Harrington, RA; PLATO Study Group,
Published in: Stroke
August 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

August 2013

Volume

44

Issue

8

Start / End Page

e95 / e96

Related Subject Headings

  • Thrombosis
  • Stroke
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Neurology & Neurosurgery
  • Humans
  • Adenosine
  • Acute Coronary Syndrome
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
James, S. K., Storey, R. F., Pieper, K. S., Cannon, C. P., Becker, R. C., Steg, P. G., … PLATO Study Group, . (2013). Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke, 44(8), e95–e96. https://doi.org/10.1161/strokeaha.113.002069
James, Stefan K., Robert F. Storey, Karen S. Pieper, Christopher P. Cannon, Richard C. Becker, Philippe Gabriel Steg, Lars Wallentin, Robert A. Harrington, and Robert A. PLATO Study Group. “Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".Stroke 44, no. 8 (August 2013): e95–96. https://doi.org/10.1161/strokeaha.113.002069.
James SK, Storey RF, Pieper KS, Cannon CP, Becker RC, Steg PG, et al. Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke. 2013 Aug;44(8):e95–6.
James, Stefan K., et al. “Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".Stroke, vol. 44, no. 8, Aug. 2013, pp. e95–96. Epmc, doi:10.1161/strokeaha.113.002069.
James SK, Storey RF, Pieper KS, Cannon CP, Becker RC, Steg PG, Wallentin L, Harrington RA, PLATO Study Group. Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke. 2013 Aug;44(8):e95–e96.

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

August 2013

Volume

44

Issue

8

Start / End Page

e95 / e96

Related Subject Headings

  • Thrombosis
  • Stroke
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Neurology & Neurosurgery
  • Humans
  • Adenosine
  • Acute Coronary Syndrome
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences